TRPV1-targeting Therapy
Heart Failure / Cardiac Hypertrophy
PreclinicalResearch/Patent Stage
Key Facts
Indication
Heart Failure / Cardiac Hypertrophy
Phase
Preclinical
Status
Research/Patent Stage
Company
About Gb Sciences
Gb Sciences is a Las Vegas-based biopharmaceutical company founded in 2009 with a mission to bridge botanical medicine and modern drug discovery. Its core strategy utilizes the AI-powered PhAROS platform to deconvolute plant mixtures into defined, synergistic drug candidates. The company's key achievement is a patented, cannabinoid-based Parkinson's disease therapy with positive animal proof-of-concept data, now partnered for first-in-human trial sponsorship, alongside a broader preclinical pipeline.
View full company profile